Literature DB >> 15589016

Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults.

Iftikhar J Kullo1, Andrea E Cassidy, Patricia A Peyser, Stephen T Turner, Patrick F Sheedy, Lawrence F Bielak.   

Abstract

Metabolic syndrome was associated with the presence and quantity of coronary artery calcium, a marker of subclinical coronary atherosclerosis, in 1,129 asymptomatic adults, ages 20 to 79 years, from a community-based study. The association was independent of 10-year risk of coronary heart disease based on the Framingham risk score.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15589016     DOI： 10.1016/j.amjcard.2004.08.038

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  9 in total

1.  Metabolic syndrome as an underlying disease entity and its relationship to subclinical atherosclerosis in Andean Hispanics.

Authors:  Diana A Chirinos; Josefina Medina-Lezama; William Arguelles; Ronald Goldberg; Neil Schneiderman; Zubair Khan; Oscar O Morey; Muhammad Waheed Raja; Roberto Paz; Julio A Chirinos; Maria M Llabre
Journal:  Metab Syndr Relat Disord       Date:  2013-11-08       Impact factor: 1.894

Review 2.  Coronary artery calcium screening in persons with metabolic syndrome and diabetes: implications for prevention.

Authors:  David M Tehrani; Shaista Malik; Nathan D Wong
Journal:  Metab Syndr Relat Disord       Date:  2013-02-25       Impact factor: 1.894

3.  Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.

Authors:  Dimitrios Daoussis; Vasileios F Panoulas; Holly John; Tracey E Toms; Ioannis Antonopoulos; Gareth Treharne; Peter Nightingale; Karen M J Douglas; George D Kitas
Journal:  Clin Rheumatol       Date:  2010-04-16       Impact factor: 2.980

4.  Relation of the metabolic syndrome to quantity of coronary atherosclerotic plaque.

Authors:  Javed Butler; Eline A Q Mooyaart; Nina Dannemann; Fabian Bamberg; Michael D Shapiro; Maros Ferencik; Thomas J Brady; Udo Hoffmann
Journal:  Am J Cardiol       Date:  2008-02-11       Impact factor: 2.778

5.  Relation of coronary atherosclerosis and metabolic syndrome in asymptomatic subjects: evaluation with coronary CT angiography.

Authors:  Jaeil Ryu; Hwan Seok Yong; Sik Huh; Eun-Young Kang; Ok Hee Woo
Journal:  Int J Cardiovasc Imaging       Date:  2013-11-02       Impact factor: 2.357

6.  Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

Authors:  Hui-Ping Gong; Yi-Meng Du; Li-Na Zhong; Zhao-Qiang Dong; Xin Wang; Yong-Jun Mao; Qing-Hua Lu
Journal:  Lipids Health Dis       Date:  2011-01-19       Impact factor: 3.876

7.  Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis.

Authors:  Shaista Malik; Matthew J Budoff; Ronit Katz; Roger S Blumenthal; Alain G Bertoni; Khurram Nasir; Moyses Szklo; R Graham Barr; Nathan D Wong
Journal:  Diabetes Care       Date:  2011-08-15       Impact factor: 19.112

8.  Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis.

Authors:  André Luiz Cerqueira de Almeida; Gisela Teixido-Tura; Eui-Young Choi; Anders Opdahl; Verônica R S Fernandes; Colin O Wu; David A Bluemke; João A C Lima
Journal:  Arq Bras Cardiol       Date:  2014-04       Impact factor: 2.000

9.  Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium progression: the Rancho Bernardo Study.

Authors:  Caroline K Kramer; Denise von Mühlen; Jorge L Gross; Gail A Laughlin; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2008-10-13       Impact factor: 17.152
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.